Pivotal is providing its specialized clinical research services for the conduct of a clinical trial in patients with COVID-19

by Pivotal

4 years ago
hyperimmune plasma, covid-19, clinical trial

The clinical trial, which plans to include a total of up to 300 patients, has recently begun to include the first patients in Madrid and will incorporate up to 25 European center.

Pivotal está proporcionando sus servicios especializados de investigación clínica en España para la realización de un ensayo clínico en pacientes con COVID-19

by Pivotal

4 years ago
covid-19, investigación clínica, ensayo clínico, plasma hiperinmune

·El ensayo clínico, que tiene previsto incluir un total de hasta 300 pacientes, ha comenzado recientemente a incluir los primeros pacientes en Madrid e irá incorporando otros centros en todo el ter...

Pivotal Acquires Akcelis, an Industry Leader in Patient Engagement, Recruitment and Retention

by Pivotal

4 years ago
Akcelis, clinical trials, recruitment, patients, biofarmaceutics

Pivotal announced today the acquisition of Akcelis BVBA, a leading full-service provider of patients´ enrollment and retention solutions for clinical trials in the life sciences´ industry.

Pivotal to provide services to Lucid Diagnostics´ clinical studies for its GI in-vitro diagnostics EsoGuard™ and EsoCheck™ to facilitate diagnosis of Barrett’s Esophagus

by Pivotal

4 years ago
esophagus, cancer, Lucid Diagnostics

Pivotal announced today that it has been contracted by Lucid Diagnostics Inc., a New York City-based company subsidiary of PAVmed (NASDAQ: PAVM), to provide expert clinical research services for it...

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer

by Pivotal

5 years ago
Pivotal, clinical trials, drug, melanoma, lung cancer

Pivotal, a specialist CRO, has been awarded two clinical trials for a novel investigational immunotherapy drug and patient enrolment has now started. Pivotal will use its deep knowledge of Oncology...

Pivotal ha comenzado el reclutamiento en un nuevo ensayo fase II en pacientes con la enfermedad de von Hippel-Lindau (VHL) y cáncer renal

by Pivotal

5 years ago
enfermedad hereditaria, enfermedad de von Hippel-Lindau, gen VHL, cáncer renal

Esta nueva colaboración tiene como objetivo acelerar el lanzamiento de nuevos tratamientos para cánceres difíciles de tratar. Dicha colaboración permitirá a los pacientes acceder a nuevos tratami...

Pivotal´s milestone in the European Society for Medical Oncology Congress

by Pivotal

6 years ago
Pivotal

On Tuesday, October 23rd, the European Society for Medical Oncology Congress (ESMO) ended its annual Congress in Munich with over 26,000 oncology professionals from all over the world. This congress w...

Pivotal and Palobiofarma collaborate on a novel mechanism of action oral treatment in Asthma

by Pivotal

6 years ago
asthma, adenosine, PBF-680, FEV1

Asthma is a chronic respiratory disease characterized by airway inflammation and affecting all age groups. Its prevalence is increasing in many countries, especially among children. Prevalence of asth...

PIVOTAL y APRO se asocian para desarrollar 3 Ensayos Promovidos por Investigador en tumores genitourinarios

by Pivotal

6 years ago
inhibidores PD-L1, ensayos clínicos, terapias dirigidas

La nueva colaboración tiene como objetivo acelerar aún más el desarrollo de los Ensayos Promovidos por Investigador (ISTs/IITs, por sus siglas en inglés) con interesantes combinaciones de tratamie...